MOLNR Stock Overview
J. Molner AS, a pharmaceutical company, provides research and development services for pharmaceutical companies in the United States, Canada, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
J. Molner AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €14.60 |
| 52 Week High | €18.00 |
| 52 Week Low | €5.10 |
| Beta | 0 |
| 1 Month Change | -5.81% |
| 3 Month Change | -13.35% |
| 1 Year Change | 177.57% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 89.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| MOLNR | EE Life Sciences | EE Market | |
|---|---|---|---|
| 7D | -3.3% | -0.9% | 0.4% |
| 1Y | 177.6% | -11.6% | -10.1% |
Return vs Industry: MOLNR exceeded the EE Life Sciences industry which returned -11.6% over the past year.
Return vs Market: MOLNR exceeded the EE Market which returned -10.1% over the past year.
Price Volatility
| MOLNR volatility | |
|---|---|
| MOLNR Average Weekly Movement | 6.2% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 2.3% |
| 10% most volatile stocks in EE Market | 6.4% |
| 10% least volatile stocks in EE Market | 1.4% |
Stable Share Price: MOLNR has not had significant price volatility in the past 3 months.
Volatility Over Time: MOLNR's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of EE stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | n/a | www.jmolner.com |
J. Molner AS, a pharmaceutical company, provides research and development services for pharmaceutical companies in the United States, Canada, and Europe. It offers generic drug development, analytical chemistry, European market release, and ongoing stability services for sterile injectable and dermatology drugs. The company was founded in 2015 and is based in Tallinn, Estonia.
J. Molner AS Fundamentals Summary
| MOLNR fundamental statistics | |
|---|---|
| Market cap | €25.12m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MOLNR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOLNR income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MOLNR perform over the long term?
See historical performance and comparison